🔎 Trials Near Me

Почетна › Неуробластом › Alabama

Kliničke studije za Неуробластом u državi Alabama

8 studija za Неуробластом traži učesnike na lokacijama u državi Alabama.

Gradovi u državi Alabama

Zvanični tekst studije (na engleskom)

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • University of Alabama/Children's of Alabama, Birmingham
Тражи се учесникФаза 1/2
До 30 година · Оба пола · Ажурирано 12. 11. 2026. · NCT06541262

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Children's Hospital of Alabama, Birmingham
  • USA Health Strada Patient Care Center, Mobile
Тражи се учесникФаза 3
До 30 година · Оба пола · Ажурирано 30. 10. 2026. · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • University of Alabama/Children's of Alabama, Birmingham
Тражи се учесникФаза 2
До 22 година · Оба пола · Ажурирано 4. 9. 2026. · NCT02559778

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • University of Alabama/Children's of Alabama, Birmingham
Тражи се учесникФаза 1/2
До 26 година · Оба пола · Ажурирано 3. 9. 2026. · NCT06465199

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Children's Hospital of Alabama, Birmingham
Тражи се учесникФаза 3
365 Days – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Hospital of Alabama, Birmingham
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT04851119

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  • University of Alabama/Children's of Alabama, Birmingham
Тражи се учесникФаза 2
12 Months – 21 Years · Оба пола · Ажурирано 12. 8. 2026. · NCT05489887

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Children's Hospital of Alabama/UAB, Birmingham
Тражи се учесникФаза 2
18 Months – 40 Years · Оба пола · Ажурирано 12. 8. 2025. · NCT05135975

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.